SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank79
3Y CAGR+10.6%
5Y CAGR+23.3%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+10.6%/yr
vs +4.4%/yr prior
5Y CAGR
+23.3%/yr
Recent deceleration
Acceleration
+6.2pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.57 | -4.6% |
| 2024 | 7.94 | +46.3% |
| 2023 | 5.43 | -3.0% |
| 2022 | 5.59 | +32.9% |
| 2021 | 4.21 | +58.6% |
| 2020 | 2.65 | -34.8% |
| 2019 | 4.07 | -13.5% |
| 2018 | 4.71 | -11.5% |
| 2017 | 5.32 | -24.4% |
| 2016 | 7.04 | - |